Nalu Bio

Other Pharmaceuticals and Biotechnology · San Francisco, CA · Founded 2019 · Privately Held (backing)

Developer of a drug discovery tool designed to accelerate the development of prescription and nonprescription health products targeting the endocannabinoid system (ECS). Nalu Bio is based in San Francisco, CA and was founded in 2019. It has raised $13.5 million across 2 recorded rounds; the latest was an accelerator round in Mar 2025.

Last price · $/share
—
Implied valuation
—
Total raised
$13.5M
Last round
Accelerator/Incubator
Mar 2025

Who backs Nalu Bio?

10 investors
InvestorType
Springboard EnterprisesOther
Flybridge (New York)Venture capital
XFactor VenturesVenture capital
Sacramento AngelsAngel
Bonaventure Equity—
Brown Angel Group—
Everest Financial—
Golden Seeds—
Intrinsic Capital Partners—
Portfolia—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Nalu Bio investors

10 investors are on record for Nalu Bio, including Springboard Enterprises, Flybridge (New York), XFactor Ventures and Sacramento Angels. The seed round in Jan 2023 drew 11 investors.

Free account
More of Nalu Bio with a free account
  • ·Watch Nalu Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 10 firms already write checks for companies like Nalu Bio in other pharmaceuticals and biotechnology. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View